+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hydroxychloroquine"

Hydroxychloroquine Global Market Report 2024 - Product Thumbnail Image

Hydroxychloroquine Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
COVID-19 Current Therapy Global Market Report 2024 - Product Thumbnail Image

COVID-19 Current Therapy Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Still's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Still's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
US Alopecia Areata - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

US Alopecia Areata - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • November 2023
  • 115 Pages
  • United States
From
Coronavirus (COVID-19) Current Therapy Global Market Report 2023 - Product Thumbnail Image

Coronavirus (COVID-19) Current Therapy Global Market Report 2023

  • Report
  • February 2023
  • 250 Pages
  • Global
From
Global Hydroxychloroquine Sulphate Market Outlook 2026 - Product Thumbnail Image

Global Hydroxychloroquine Sulphate Market Outlook 2026

  • Report
  • May 2020
  • 117 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

Hydroxychloroquine is a drug used to treat immune disorders, such as lupus and rheumatoid arthritis. It is an antimalarial drug, meaning it is used to prevent and treat malaria. It is also used to treat other autoimmune diseases, such as discoid lupus erythematosus and systemic lupus erythematosus. Hydroxychloroquine is a relatively safe drug, with few side effects. It is also relatively inexpensive, making it a popular choice for treating immune disorders. Hydroxychloroquine is available in both generic and brand-name forms. It is available in tablet, capsule, and liquid forms. It is also available in combination with other drugs, such as methotrexate and sulfasalazine. The hydroxychloroquine market is highly competitive, with many companies offering the drug. Some of the companies in the market include Mylan, Teva Pharmaceuticals, Sandoz, and Pfizer. Show Less Read more